PhaseBio Pharmaceuticals, Inc. (PHAS) Social Stream PHAS Home News Ratings Charts PhaseBio Pharmaceuticals, Inc. (PHAS): $0.07 0.02 (-26.21%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum D Stability D Sentiment Get Rating Quality D Add PHAS to Watchlist Sign Up Industry: Medical - Pharmaceuticals Industry NR Ranked #119 of 164 in industry See All 'A' Rated Buy Stocks Loading social stream, please wait... Most Popular Stories View All • Stock Market Expert Predicts 3-6 Months of Pain • 3 Pharmaceutical Stocks Addressing Global Health Challenges • 3 Tech Stocks Analysts Say Are "Strong Buys" for 2025 • 3 Tech Stocks Under $20 With Breakout Potential • How Bad Will 2025 Be for Stocks? View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
Loading social stream, please wait...